Low- versus high-dose rituximab for antibody-mediated rejection after kidney transplantation

Transpl Int. 2013 Feb;26(2):e12-4. doi: 10.1111/tri.12015. Epub 2012 Dec 1.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Female
  • Glomerular Filtration Rate
  • Graft Rejection / drug therapy*
  • HLA Antigens / analysis
  • Humans
  • Immunologic Factors / therapeutic use
  • Kidney Transplantation / pathology*
  • Male
  • Middle Aged
  • Risk Factors
  • Rituximab
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • HLA Antigens
  • Immunologic Factors
  • Rituximab